Literature DB >> 34962637

Single-Run Catalysis and Kinetic Control of Human Telomerase Holoenzyme.

Qiu-Xing Jiang1,2,3.   

Abstract

Genome stability in eukaryotic cells relies on proper maintenance of telomeres at the termini of linear chromosomes. Human telomerase holoenzyme is required for maintaining telomere stability in a majority of proliferative human cells, making it essential for control of cell division and aging, stem cell maintenance, and development and survival of tumor or cancer. A dividing human cell usually contains a limited number of active telomerase holoenzymes. Recently, we discovered that a human telomerase catalytic site undergoes catalysis-dependent shut-off and an inactive site can be reactivated by cellular fractions containing human intracellular telomerase-activating factors (hiTAFs). Such ON-OFF control of human telomerase activity suggests a dynamic switch between inactive and active pools of the holoenzymes. In this review, we will link the ON-OFF control to the thermodynamic and kinetic properties of human telomerase holoenzymes, and discuss its potential contributions to the maintenance of telomere length equilibrium. This treatment suggests probabilistic fluctuations in the number of active telomerase holoenzymes as well as the number of telomeres that are extended in a limited number of cell cycles, and may be an important component of a fully quantitative model for the dynamic control of telomerase activities and telomere lengths in different types of eukaryotic cells.
© 2021. Springer Nature Switzerland AG.

Entities:  

Keywords:  Cancer cell survival; Catalysis-dependent inactivation; Cell aging; Cell cycle; Energetics and kinetics; Human intracellular telomerase-activating factor (hiTAF); Human telomerase holoenzyme; ON-OFF control; Probabilistic fluctuations; Reactivation and activation

Mesh:

Substances:

Year:  2022        PMID: 34962637      PMCID: PMC9385204          DOI: 10.1007/5584_2021_676

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   3.650


  117 in total

1.  Unlimited mileage from telomerase?

Authors:  T de Lange; R A DePinho
Journal:  Science       Date:  1999-02-12       Impact factor: 47.728

2.  Stable association of hsp90 and p23, but Not hsp70, with active human telomerase.

Authors:  H L Forsythe; J L Jarvis; J W Turner; L W Elmore; S E Holt
Journal:  J Biol Chem       Date:  2001-03-23       Impact factor: 5.157

Review 3.  CST meets shelterin to keep telomeres in check.

Authors:  Marie-Josèphe Giraud-Panis; M Teresa Teixeira; Vincent Géli; Eric Gilson
Journal:  Mol Cell       Date:  2010-09-10       Impact factor: 17.970

Review 4.  Telomerase Mechanism of Telomere Synthesis.

Authors:  R Alex Wu; Heather E Upton; Jacob M Vogan; Kathleen Collins
Journal:  Annu Rev Biochem       Date:  2017-01-30       Impact factor: 23.643

5.  Protein composition of catalytically active human telomerase from immortal cells.

Authors:  Scott B Cohen; Mark E Graham; George O Lovrecz; Nicolai Bache; Phillip J Robinson; Roger R Reddel
Journal:  Science       Date:  2007-03-30       Impact factor: 47.728

Review 6.  Shaping human telomeres: from shelterin and CST complexes to telomeric chromatin organization.

Authors:  Ci Ji Lim; Thomas R Cech
Journal:  Nat Rev Mol Cell Biol       Date:  2021-02-09       Impact factor: 94.444

7.  Telomeres, telomerase and cancer.

Authors:  C W Greider; E H Blackburn
Journal:  Sci Am       Date:  1996-02       Impact factor: 2.142

8.  Telomerase and ATM/Tel1p protect telomeres from nonhomologous end joining.

Authors:  Simon W-L Chan; Elizabeth H Blackburn
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

9.  Telomere DNA G-quadruplex folding within actively extending human telomerase.

Authors:  Linnea I Jansson; Jendrik Hentschel; Joseph W Parks; Terren R Chang; Cheng Lu; Rishika Baral; Clive R Bagshaw; Michael D Stone
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-24       Impact factor: 12.779

Review 10.  DNA and RNA quadruplex-binding proteins.

Authors:  Václav Brázda; Lucia Hároníková; Jack C C Liao; Miroslav Fojta
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.